Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen D W Beck

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Indian Journal of Urology : IJU : Journal of the Urological Society of India|June 11, 2010
Management options for stage 1 nonseminomatous germ cell tumors of the testisStephen D W Beck
Cancer|October 24, 2007
The role of postchemotherapy surgery in managing metastatic germ cell tumorsStephen D W Beck
The Journal of Urology|January 18, 2011
Editorial commentStephen D W Beck
The Journal of Urology|March 21, 2015
Stage 1 testicular seminoma: radiotherapyStephen D W Beck
World Journal of Urology|July 16, 2009
Management of the post chemotherapy subcentimeter residual mass: the case for observationStephen D W Beck, Richard S Foster
World Journal of Urology|March 9, 2006
Long-term outcome of retroperitoneal lymph node dissection in the management of testis cancerStephen D W Beck, Richard S Foster
The Journal of Urology|December 11, 2003
Tumor marker levels in post-chemotherapy cystic masses: clinical implications for patients with germ cell tumorsStephen D W Beck, Manish I Patel, Joel Sheinfeld
Urologic Oncology|September 17, 2013
Current and future biologic markers for disease progression and relapse in testicular germ cell tumors: a reviewTimothy A Masterson, Kevin R Rice, Stephen D W Beck
Clinical Prostate Cancer|July 29, 2004
Prostatic intraepithelial neoplasia: an updateLiang Cheng, Ryan F Paterson, Stephen D W Beck, et al.
Urology|October 1, 2005
Does wide primary perirectal dissection during radical retropubic prostatectomy alter pathologic and biochemical outcomes?Andrew M Dussinger, Stephen D W Beck, Liang Cheng, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Indian Journal of Urology : IJU : Journal of the Urological Society of India|June 11, 2010
Management options for stage 1 nonseminomatous germ cell tumors of the testisStephen D W Beck
Cancer|October 24, 2007
The role of postchemotherapy surgery in managing metastatic germ cell tumorsStephen D W Beck
The Journal of Urology|January 18, 2011
Editorial commentStephen D W Beck
The Journal of Urology|March 21, 2015
Stage 1 testicular seminoma: radiotherapyStephen D W Beck
World Journal of Urology|July 16, 2009
Management of the post chemotherapy subcentimeter residual mass: the case for observationStephen D W Beck, Richard S Foster
World Journal of Urology|March 9, 2006
Long-term outcome of retroperitoneal lymph node dissection in the management of testis cancerStephen D W Beck, Richard S Foster
The Journal of Urology|December 11, 2003
Tumor marker levels in post-chemotherapy cystic masses: clinical implications for patients with germ cell tumorsStephen D W Beck, Manish I Patel, Joel Sheinfeld
Urologic Oncology|September 17, 2013
Current and future biologic markers for disease progression and relapse in testicular germ cell tumors: a reviewTimothy A Masterson, Kevin R Rice, Stephen D W Beck
Clinical Prostate Cancer|July 29, 2004
Prostatic intraepithelial neoplasia: an updateLiang Cheng, Ryan F Paterson, Stephen D W Beck, et al.
Urology|October 1, 2005
Does wide primary perirectal dissection during radical retropubic prostatectomy alter pathologic and biochemical outcomes?Andrew M Dussinger, Stephen D W Beck, Liang Cheng, et al.
Pageof 5